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Abstract Emerging evidence indicates that cadmium (Cd)
is able to regulate gene expression, drastically affecting the
pattern of transcriptional activity in human normal and path-
ological cells. We have already shown that exposure of
MDA-MB231 breast cancer cells to 5 μM CdCl2 for 96 h,
apart from significantly affecting mitochondrial metabolism,
induces modifications of the expression level of genes coding
for members of stress response-, mitochondrial respiration-,
MAP kinase-, NF–κB-, and apoptosis-related pathways. In
the present study, we have expanded the knowledge on the
biological effects of Cd–breast cancer cell interactions, indi-
cating PLP2 (proteolipid protein-2) as a novel member of the
list of Cd-upregulated genes by MDA-MB231 cancer cells
and, through the application of transfection techniques with
specific antisense oligonucleotides, we have demonstrated
that such over-expression may be an upstream event to some
of the changes of gene expression levels already observed in
Cd-treated cells, thus unveiling new possible molecular rela-
tionship between PLP2 and genes linked to the stress and
apoptotic responses.
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Introduction
The industrial and environmental pollutant cadmium (Cd) is
known to intervene in biological systems by accumulating into
living cells via import through different cell surface systems,
e.g., ZIP transporters, Fe++/H+ cotransporter divalent metal
transporter 1, and CaV3.1 and −3.2 T-type Ca++ channels
and targeting the Zn-binding domains of several metallopro-
teins, thereby interfering with or preventing Zn-dependent
cellular functions [1, 2]. Cd is not essential for the human
body and has no known useful biological functions. On the
other hand, its effective role in both cancer initiation/progres-
sion, mostly due to its activating action on oncogenes via β-
catenin and in apoptotic promotion of normal and tumoral
cytotypes has been widely recognized [3, 4]. Noteworthy is
the increasing evidence which indicates that Cd is capable of
regulating gene expression, thereby acting as a transcriptional
modulator for both prokaryotic and lower/upper eukaryotic
cells, in normal and pathologic conditions [5].
We have previously reported that, when the highly tumori-
genic triple-negative MDA-MB231 cell line, selected as an in
vitromodel of “aggressive” breast carcinoma, is treated for 96 h
with CdCl2, such exposure determines a decrease of cell pro-
liferation with a 50% inhibitory concentration (IC50) of 5μM, a
concentration similar to levels encountered in occupational
exposure. We also showed the effect of metal treatment on
several biological functions, such as the significant increase of
mitochondrial respiratory activity, the impairment of intra-
mitochondrial protein import process, and the accumulation
of reactive oxygen species. Interestingly, additional evidence
demonstrated the effect of 5 μM CdCl2 exposure for 96 h on
Published in the topical collection Metallomics with guest editors Uwe
Karst and Michael Sperling.
A. Longo :M. Librizzi : C. Luparello (*)
Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari
(STEMBIO), Università di Palermo,






the modification of the expression level of selected genes,
including those coding for members of stress response-, mito-
chondrial respiration-, MAP kinase-, NF–κB-, and apoptosis-
related pathways, by MDA-MB231 cells, which therefore
appeared to be a useful cell model system for the study of the
transcriptional modulation exerted by the metal [6–9].
In order to expand the list of Cd-responsive genes involved
in the cytotoxic action exerted by the metal on the breast
cancer cell line under study, here we have focused our atten-
tion on a novel differentially displayed cDNA product arising
from polymer chain reaction (PCR)-mediated analysis of tran-
script arrays, i.e., that corresponds to a portion of proteolipid
protein 2 (PLP2) coding sequence. In the present paper, we
report that exposure to CdCl2 promotes the upregulation of
PLP2 expression by MDA-MB231 cancer cells and, through
the application of transfection techniques with specific anti-
sense oligonucleotides (asODN), we demonstrate that such
over-expression may be an upstream event to changes of gene
expression levels in Cd-treated cells, the already-observed
upregulation of caspase 8 being noteworthy [6], thus unveil-
ing the new possible molecular relationship between PLP2
and genes linked to the stress and apoptotic responses.We also
propose that PLP2 could be taken into consideration as an
additional putative gene expression signature to serve in both
prognostic and predictive assessments for the health risk of
exposure to environmental Cd.
Materials and methods
Cell cultures and transfection
The MDA-MB231 breast cancer cell line was routinely grown
in RPMI 1640 medium plus 10% fetal calf serum, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 2.5 mg/L amphoter-
icin B (Invitrogen, Carlsbad/CA, USA), at 37 °C in a 5% CO2
atmosphere. The HB2 breast epithelial cell line (courtesy of
Cancer Research, UK) was routinely grown in high glucose–
DMEM medium plus 10% fetal calf serum (Invitrogen), 5 μg
hydrocortisone/ml (Sigma, St. Louis,MO/USA), 10μg bovine
insulin (Sigma), and the same antibiotic/antimycotic mixture,
at 37 °C in a 5%CO2 atmosphere. For Cd treatment, cells were
plated in the presence of 5 μM CdCl2 and grown for 96 h.
A directed antisense strategy was applied to downregulate
PLP2 expression, as already described [10]. The sequence of
the phosphorothioate asODN targeted to PLP2 was 5′-GTG
GTTTCGAGGACGCTGT-3′, complementary to bases 8–27
of its mRNA. The RNAdraw software [11] was utilized to
predict the secondary structure of PLP2 mRNA (Fig. 1). The
asODN was delivered to cells as a complex with Lipofectin
(Invitrogen), according to manufacturer’s instructions, in
serum- and antibiotic/antimycotic-free medium. Control assays
were performed with Lipofectin only.
Crystal violet assay
Aliquots of 104 cells were plated into 96-well plates and
grown for 96 h in the presence of either CdCl2/Lipofectin
or CdCl2/Lipofectin/PLP2 asODN. For indirect cell num-
ber evaluation, nuclei were stained with 0.2% crystal
violet in 2% ethanol, the dye eluted with 1% sodium
dodecylsulfate (SDS) and quantitated spectrophotometri-
cally at λ0570 nm.
RNA extraction and reverse transcription
Isolation of total RNA was carried out with Trizol reagent
(Sigma). Before the reverse transcription, the total RNA was
treated with RQ1 RNase-free DNase (Promega, Madison, WI,
USA) and its quality and integrity checked through agarose
gel electrophoresis in denaturing conditions. Enrichment of
samples for mRNAs, as required for differential display-
polymerase chain reaction (DD-PCR), was achieved by treat-
ment with Terminator™ 5′-Phosphate-Dependent Exonuclease
(Epicentre, Madison, WI/USA), following manufacturer’s
instructions. The cDNAs were synthesized using SuperScript
II reverse transcriptase (Invitrogen) in the presence of 100 ng
random 6-mer primers (Sigma), 50 U RNase inhibitor (Prom-
ega), and 0.5 mM each of dNTPs; reverse transcription was
carried out for 60 min at 42 °C, followed by treatment with 2 U
RNase H (USB, Cleveland, OH, USA) for 20 min at 37 °C.
The quality of cDNAwas checked by amplification of “house-
keeping” 18S cDNA
Differential display-polymerase chain reaction (DD-PCR)
For differential expression analysis, DD-PCR experiments
were performed as already reported [e.g., 9, 12] using the
arbitrary 10-mer primers designed by Sokolov and Prockop
[13], in combinations of two. The PCR amplification was
carried out using 25 pmoles of each of two primers, 1–2 μl
Fig. 1 Detail of the secondary structure of the human PLP2 mRNA as
predicted by the RNAdraw program. The arrows point to the extrem-
ities of the sequence recognized by PLP2 asODN
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of the cDNA template, and 3.6 U of AmpliTaq DNA Poly-
merase, Stoffel fragment (Perkin Elmer, USA), in 50 μl of the
appropriate reaction mixture. The thermal cycle used was a
denaturation step of 94.5 °C for 3 min, followed by 45 cycles
of 94.5 °C for 1 min, 34 °C for 1 min, 72 °C for 1 min, and a
final extension of the product for 10 min at 72 °C.
After PCR amplification, 8 μl of the amplification
products were electrophoresed in a non-denaturing 6%
polyacrylamide gel in a sequencing apparatus at constant
55 W and the band pattern visualized via silver staining.
Evaluation of band size was performed with SigmaGel
software (SPSS, USA). For re-amplification of the select-
ed differentially displayed band, the silver-stained gel was
exhaustively washed with double-distilled water and the
band of interest carefully scratched from the gel with a
sterile syringe needle and used as template for PCR ampli-
fications performed as described in the following section.
Several cycles of amplification and electrophoresis were
repeated until a single pure band was visualized in the gel
and eluted using Ultrafree DA filter columns (Millipore,
Bedford MA/USA).
The sequence of the purified PCR product was subsequent-
ly determined by MWG Biotech sequencing service, and
DNA sequence similarity was searched with the BLAST
algorithm [14] available online.
Conventional PCR
PCR analysis was performed using 2.5 μM of appropriate
sense and antisense primers, 1 U RedTaq DNA polymerase
(Sigma)/μl, 200 μM each of deoxyribonucleotides diphos-
phates, and 1 μl of the cDNA template obtained from total
RNA. The latter one was omitted in negative controls. All the
primers used were from Luparello et al. and Luparello and
Sirchia [10, 15, 16]. The thermal cycle used was a denatur-
ation step of 94 °C for 3 min, followed by 35 cycles of 94 °C
for 30 s, the appropriate annealing temperature for 30 s, and
72 °C for 30 s. A final extension of the product was performed
for 5 min at 72 °C. PCR products were analyzed by 2%
agarose gel electrophoresis and visualized byGel Red staining
(Biotium, Hayward, CA, USA) under UV light
Semi-quantitative “multiplex”
Semi-quantitative “multiplex” (SM-PCR) was carried out as
previously reported [e.g., 12]. Essentially, the cDNA species
of interest was co-amplified with cDNA from 18S rRNA
over a range of cycles, followed by 2% agarose electropho-
resis and Gel Red stain. Cycle profile was a denaturation
step of 94.5 °C for 3 min., followed by cycles of 94 °C for
30 s, 57 °C for 30 s, 72 °C for 30 s, and a final extension of
the product for 5 min at 72 °C. Cycles were limited to the
minimum necessary for detection. The intensities of the
bands of interest, evaluated with SigmaScan software, were
normalized for those of 18S, and plotted as a function of
cycle number. Exponential regression equations fitted to the
curves were used to calculate the number of cycles neces-
sary to reach a normalized intensity threshold value01 for
each sample. The relative difference in abundance between
two samples was taken as 2n where n is the difference
between the numbers of cycles required by the samples to
reach the threshold. Two different RNA preparations from
each experimental condition were pooled to make the differ-
ences more significant between the expression levels, if any.
Statistics
The results in histograms are presented as average±SEM of
triplicate experiments; the SEM is indicated as vertical bars
in the figures. Data were analyzed using software-assisted
analysis of variance (SigmaStat v.2; SPSS, Chicago, IL,
USA), and p<0.05 was taken as the minimal level of statis-
tical significance.
Results
PLP2 is upregulated in Cd-treated MDA-MB231 breast
cancer cells
In order to search for novel genes whose modification of
expression level might be linked to the lethal phenotype in-
duced by Cd exposition, in a first set of assays, we submitted
cDNA preparations, obtained from MDA-MB231 cells grown
in the presence of 5 μM CdCl2 for 96 h, to DD-PCR as
described. Among the several differentially displayed bands
present in the gel, we focused our attention on an amplification
band of about 110 bp, obtained utilizing the BS76/BS78
combination of arbitrary primers, which was present only in
the electrophoretic lane corresponding to the cDNA prepara-
tion from metal-treated cells (Fig. 2a). The differentially dis-
played cDNA fragment was purified as described and
submitted to sequencing. Using BLASTN software, homology
(score0111 bits, expect03e–22) was found in the non-
redundant nucleic acid sequence database (nr–nt) between
the sequence obtained and that of region 6158–6217 of the
coding sequence for Homo sapiens proteolipid protein 2
(PLP2) (Acc. nr. NG_016420), a.k.a. A4 differentiation-
dependent protein (A4) [17].
We then checked the differential expression of PLP2 by
conventional PCR amplification in the presence of specific
primers. As shown in Fig. 2b, after the PCR amplification,
we found a product of the expected size (150 bp) in both
experimental conditions, indicating that expression of PLP2
was switched-on in both control and Cd-exposed cells. For
semi-quantitative evaluation, the cDNA preparations from
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cells cultured in control conditions and in the presence of
CdCl2 were submitted to SM-PCR, as described. Figure 2c
shows a plot of normalized data for PLP2 versus cycle
number, with exponential curve fits. Calculation of the
relative difference in transcript abundance revealed that
treatment of MDA-MB231 cells with 5 μM CdCl2 for
96 h promoted upregulation of PLP2 by about twofold
with respect to control cells, thus validating the DD-PCR
findings.
In a parallel assay, non-tumoral HB2 epithelial breast
cells were submitted to the same exposure to the metal and
the cDNA preparations from control and treated samples
analyzed by SM-PCR for PLP2, once an amplification band
of the expected size in both experimental conditions (not
shown) was found. As shown in Fig. 2d, similar to what was
found for MDA-MB231 cancer cells; also in HB2 cells,
CdCl2 treatment promoted upregulation of PLP2 by about
twofold, thereby suggesting a possible generalized effect of
the metal on the modulation of such transcriptional activity.
In order to study the kinetics of Cd-dependent modula-
tion of PLP2 gene expression, preparations of control and
treated MDA-MB231 and HB2 cells obtained after shorter-
term exposures to 5 μMCdCl2 (24 and 48 h) were submitted
to SM-PCR. Since no significant difference was found for
PLP2 expression levels between control and treated cells of
both lines at these time points (data not shown), we can
assume that PLP2 upregulation is a late event triggered by
CdCl2 treatments.
Antisense-mediated downregulation of PLP2 in Cd-treated
MDA-MB231 cells is unable to affect cell morphological
appearance and proliferation rate
In order to investigate whether the increase of PLP2 expres-
sion levels might in some way be implicated in the already-
reported Cd-triggered modifications of cell morphology,
growth rate, and expression levels of stress response- and
apoptosis-related genes [6, 9]; in a second set of assays, we
induced asODN-mediated downregulation of PLP2 in MDA-
MB231 cells exposed for 96 h to 5 μM CdCl2 and evaluated
both the appearance and density of the cell culture under the
phase contrast microscope and cell number via crystal violet
assays in parallel with vector only-treated cells and non-
transfected cells, both grown in the presence of 5 μM CdCl2
for 96 h, used as controls.
Preliminarily, we checked at mRNA level whether expo-
sure to the specific asODN was successful in downregulating
PLP2, through PCR amplification of cDNA preparations. As
shown in Fig. 3a, incubation with Lipofectin-vehiculated
PLP2-asODN resulted in the prominent downregulation (of
approximately sevenfold) of PLP2, thereby confirming the
success of the transfection technique and asODN chosen that
Fig. 2 Identification of PLP2 as a differentially expressed gene in
Cd-treated MDA-MB231 and HB2 cells. a DD-PCR of cDNA
preparations from control and Cd-treated MDA-MB231 cells.
The arrow points to a band of about 110 bp, selectively displayed
in the sample obtained from cells exposed to the metal. Detail of
a 6% sequencing polyacrylamide gel, silver staining. b Conven-
tional PCR amplification of the product of PLP2 cDNA in control
and Cd-treated MDA-MB231 cells. Cycle number was 35. Aga-
rose gel 2%, Gel Red stain. c, d SM-PCR for PLP2. Represen-
tative plot of normalized data versus cycle numbers fit with an
exponential curve for MDA-MB231 (c) and HB2 (d) cells grown
in control conditions (black circle) and in the presence of CdCl2
(white circle). The dotted line represents the value01
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was able to decrease gene expression down to levels even
lower than that observed in unexposedMDA-MB231 cells. In
addition, we also checked and confirmed that incubation with
Lipofectin only did not modify the appearance and number of
Cd-exposed MDA-MB231 cells (data not shown).
The results obtained in this set of experiments indicate that
downregulation of PLP2 exerts no effect on cell morphology
and growth rate of MDA-MB231 cells exposed to the metal.
Figure 3b shows that, at the microscopic observation, both
untreated and asODN-treated cells displayed similar appear-
ance and density onto the culture plate. In line with the
observations made, the absorbance value of eluted crystal
violet of PLP2 asODN-treated cells was comparable to that
of untreated cells grown in CdCl2-containing media (Fig. 3c),
thereby suggesting that Cd-dependent PLP2 upregulation was
not directly responsible of the drastic changes in the adhesive
and survival/proliferative behavior of the cell population.
Antisense-mediated downregulation of PLP2 in Cd-treated
MDA-MB231 cells affects the expression levels of selected
heat-shock and caspase genes
We then examined whether the downregulation of PLP2
experimentally induced in Cd-treated MDA-MB231 tumor
cells might result in changes of the expression levels of
those stress response-related genes (hsf1, hsp27, hsp-75,
hsp-90β, hsc70, and grp78), apoptosis factor genes (Bcl-2,
Dap kinase,Waf-1), and caspase genes (caspase-1, caspase-
2, caspase-6, caspase-7, caspase-8, and caspase-9), whose
Cd-dependence was reported in a previous publication [6].
First, we submitted cDNA preparations obtained from un-
treated, vector only- and PLP2 asODN-treated cells exposed
to CdCl2 to conventional PCR to check whether the selected
genes were expressed. As shown in Fig. 4a, amplification
bands for all the tested cDNAs could be observed in all sets
of samples, confirming that the specific gene expression was
switched-on in control, vector only- and asODN-transfected
cells.
To check whether gene expression levels were differing
among the three experimental conditions, we then submitted
the cDNA preparations to SM-PCR. As shown in the panel of
graphs in Fig. 4b, no difference was found between the two
controls, i.e., untreated and vector only-treated cells, whereas,
when compared with controls, transfection with PLP2 asODN
resulted in the upregulation of caspase-1 (approx. tenfold),
caspase-2 (approx. fivefold), caspase-9 (approx. fivefold),
and hsp27 (approx. twofold), and in the downregulation of
caspase-8 (approx. 4.2-fold) and hsc70 (approx. 4.4-fold).
Fig. 3 Effect of transfection with PLP2 asODN on PLP2 expression,
morphological appearance, and number of Cd-treated MDA-MB231
cells. a SM-PCR for PLP2. Representative plot of normalized data
versus cycle numbers fit with an exponential curve for Cd-treated
MDA-MB231 cells either non-transfected (black down-pointing tri-
angle), transfected with Lipofectin only (white circle) or with Lip-
ofectin+PLP2 asODN (black circle). The dotted line represents the
value01. b Representative phase contrast micrographs of Cd-treated
MDA-MB231 cells either non-transfected (A) or transfected with PLP2
asODN (B). Bar020 μm. c Histogram showing the absorbance of
crystal violet eluted after lysis of stained MDA-MB231 cells cultured
in the same experimental conditions as above. The vertical bars indi-
cate the SEM of triplicate experiments; p was >0.05
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Fig. 4 Effect of transfection
with PLP2 asODN on stress
response and apoptosis-related
gene expressions by Cd-treated
MDA-MB231 cells. a Panel
showing the bands obtained
from PCR amplification of
cDNA preparations from Cd-
treated MDA-MB231 cells ei-
ther non-transfected (A), trans-
fected with Lipofectin only (B)
or with Lipofectin+PLP2
asODN (C). PCR cycle number
was 35. b SM-PCR for caspase-
1, caspase-2, caspase-8, cas-
pase-9, hsp27, and hsc70. Rep-
resentative plots of normalized
data versus cycle numbers fit
with an exponential curve for
Cd-treated cells either non-
transfected (black down-
pointing triangle), transfected
with Lipofectin only (white cir-
cle) or with Lipofectin+PLP2
asODN (black circle). c Histo-
gram showing the average
changes in expression levels of
the tested genes based on SM-
PCR assays of Cd-treated
MDA-MB231 cells transfected
with PLP2 asODN compared
with non-transfected controls
(SEM of triplicate assays was
less than 5% in each experi-
mental condition). *0p<0.05
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This suggests that PLP2 expression may be upstream and in
some way involved in the balance of hsp- and caspase mRNA
synthesis, which in turn is implicated in cell protection and
survival/death decisions. No significant difference was found
for the expression levels of hsf1, hsp75, hsp90β, grp78, Dap
kinase, Bcl-2, Waf-1, caspase-6, and caspase-7. The histo-
grams in Fig. 4c report a synopsis of the expression level
ratios of the studied genes in PLP2 asODN-transfected cells
versus control cells, both cultured for 96 h in the presence of
5 μM CdCl2.
Discussion
It is generally acknowledged that information at a molecular
level is a necessary complement to descriptive epidemiolog-
ical investigations on the effect of exposure of humans to
pollutants, providing a list of marker genes useful for risk
assessment. In the last decade, several molecular biomarkers
have been validated as specific and reliable for Cd-induced
toxicity, such as genes which encode for metallothioneins,
for factors involved in the response to oxidative stress and in
the onset of apoptosis, for signal transduction-linked recep-
tors, and for miRNAs [5].
In the present work, we have reported the differential ex-
pression of PLP2 by neoplastic MDA-MB231 cells as a re-
sponse to culture in the presence of CdCl2 at a concentration
corresponding to the IC50 after long-term exposure and the
effect of PLP2 downregulation on gene expression of Cd-
treated cells. Literature data on PLP2 are limited and fragmen-
tary to date. It is known that the protein product, encoded by a
3.5-kb five-exon gene located on chromosome X, is a compo-
nent of the endoplasmic reticulum with four trans-membrane
domains, abundantly expressed in human colonic epithelium
where it is supposed to control cell differentiation [18]. Inter-
estingly, accumulation of PLP2 mRNA was observed during
another differentiation event, i.e., that of the extraembryonic
mesoderm in the early gastrula of rabbit embryo in coincidence
with emerging morphogenetic activities at the posterior pole
[19]. PLP2 protein is likely to multimerize and form ion chan-
nel due to the similarity of its hydropathy profile with that of a
subunit of the H+ vacuolar ATPase [20]. In addition, its over-
expression was proven to be linked to enhanced migratory
activity of C–C chemokine receptor-1-expressing cells in re-
sponse to specific ligands, thus suggesting a role of plasma
membrane-bound PLP2 in chemotactic processes [21].
Interestingly, some of us previously demonstrated the upre-
gulation of PLP2 in MDA-MB231 cells submitted to a differ-
ent cytotoxic treatment, i.e., that, with 1 nM parathyroid
hormone-related peptide fragment 38–94 [16]. Here, we pro-
vide first evidence that PLP2 expression in MDA-MB231
cells can be also upregulated by “long-term” exposition to
5 μM CdCl2 and that, in turn, such over-expression, although
exerting no effect on the overall viability of the cell popula-
tion, is linked to changes in the expression levels of stress
response and caspase genes. Additional studies will be re-
quired to deeply understand the specific molecular mechanism
through which PLP2 accomplishes its effect on Cd-exposed
cells; however, the data presented here allow the following
comments:
1. Transfection studies suggest that enhanced PLP2 expres-
sion levels in response to CdCl2 might be interpreted as a
defence mechanism activated by cells in the attempt to
prevent metal toxic effect by maintaining expression of
caspase-1, caspase-2, and caspase-9 at lower levels. Al-
though examining expression at the mRNA level could
provide evidence of differences that do not necessarily
correspond to changes in enzyme activity, the observed
transcriptional activation of such caspases following ab-
rogation of PLP2 upregulation suggests that expression of
these members of the enzymatic family is specifically
under the control of a PLP2-mediated mechanism whose
nature is still to be determined.
2. Transfection studies also indicate that PLP2 upregulation
is in some way involved in restraining hsc70 downregu-
lation and hsp27 over-expression, as a likely additional
aspect of activation of cell defence mechanisms. It is
known, in fact, that a decrease in hsc70 expression may
contribute to the lowering of cell protection against reac-
tive oxygen species, in particular, as regards their activity
on membrane lipid peroxidation [22]. In addition, in Dro-
sophila cells, depletion of hsc70 has been proven to lead
to upregulation of hsp27 [23], and therefore the two events
could be linked in PLP2 asODN-transfected cells. On the
other hand, it is known that hsp27 promoter contains an
imperfect but functional estrogen-responsive element and
that Cd is a metallo-estrogen, since it binds and activates
steroid receptors [24, 25]; therefore, PLP2 might be in-
volved in the counteraction of such activating role played
by Cd on hsp27 gene. Furthermore, Kindas-Mügge et al.
[26] demonstrated the decrease of the proliferation rate of
hsp27-overexpressing MDA-MB231 cells; thus, it can be
hypothesized that PLP2-induced restraining effect on
hsp27 expression may be addressed to protect cell growth
behavior from the toxic effect of the metal.
3. Utilizing a two-hybrid yeast system in KB epithelial cells,
Wang et al. [27] had already reported that PLP2 is able to
bind BAP31, another transmembrane polytopic protein of
the endoplasmic reticulum. BAP31 is a substrate for
cleavage by caspase-8, thereby producing the apoptosis-
promoting form BAP20; on the other hand, PLP2 binding
to intact BAP31 is supposed to render cells resistant to
cytochrome c release from mitochondria and apoptosis
induction via the death receptor (extrinsic) pathway, prob-
ably counteracting the enzymatic activity of caspase-8 on
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BAP31 [28]. Interestingly, different from what was found
for the other genes, asODN-mediated downregulation of
PLP2 was found to revert the upregulation of caspase-
8 previously observed in MDA-MB231 cells exposed to
CdCl2 [6]. Although the precise molecular mechanism is
still to be understood, to our knowledge, this is the first
evidence suggesting a correlation of PLP2 and the
apoptosis-initiator caspase-8 also at gene expression level,
additional to that already proposed at enzymatic activity
level [27], thereby unveiling a novel positive interaction
between the two transcriptional events which deserves
further study.
4. Caspases form a complex enzymatic system whose mem-
bers work together in a precisely controlled proteolytic
cascade leading to auto- and mutual activation [e.g., 29].
The caspase members taken into account in the present
paper are not all those involved in the onset of apoptosis,
but only those whose gene expression levels have been
proven to change following CdCl2 treatment of MDA-
MB231 cells [15]. In particular, caspase-1, caspase-2, and
caspase-8 are involved in the death receptor pathway of
apoptosis; caspase-9 is involved in the mitochondrial
pathway, and both caspase-8 and caspase-9 activate
caspase-3, caspase-6, and caspase-7 which act as apopto-
tic executioners. Therefore, taking such complexity into
account, caution must be exercised in interpreting the data
obtained by limited gene expression analyses, although
they provide a good starting point for a more detailed
study of Cd-mediated regulation of the caspase-cascade
signalling system in malignant and immortalized epithe-
lial breast cells.
In conclusion, the present work has expanded the knowl-
edge on the biological effects of Cd–breast cancer cell inter-
actions, indicating PLP2 as a novel member of the list of Cd-
regulated genes involved in the modulation of the pattern of
transcriptional activities. Moreover, its differential expression
observed also in the non-tumoral cell line here studied, i.e.,
HB2 immortalized cells from breast epithelium, suggests that
promotion of PLP2 upregulation is likely to be a widespread
Cd-dependent phenomenon. Consequently, PLP2 could be
taken into consideration as an additional putative gene expres-
sion signature to serve in both prognostic and predictive
assessments for the health risk of exposure to concentrations
of Cd present in the occupational environment, although
further validation in a statistically significant number of cell
lines, both normal and pathological, as well as selected from
different sources, will be required to this purpose.
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